DePuy Orthopaedics
Clinical trials sponsored by DePuy Orthopaedics, explained in plain language.
Orthopaedic device division of Johnson & Johnson, focusing on joint replacement and trauma products.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New cementless knee implant aims to improve mobility in osteoarthritis patients Results expected Sep 2027 (estimated)
-
New stemless shoulder implant aims to ease arthritis pain
Disease control Recruiting nowThis study is testing a new stemless reverse total shoulder system for people with severe shoulder arthritis. About 168 participants will be randomly assigned to get the new device or a standard one. The main goal is to see if the new implant improves shoulder function and has fe…
Sponsor: DePuy Orthopaedics • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New navigation tech aims to improve hip replacement accuracy
Knowledge-focused Recruiting nowThis study looks at how well a non-invasive navigation system helps surgeons place the hip cup during total hip replacement. About 118 people with hip conditions like arthritis or hip dysplasia will take part. The goal is to see if the actual cup position matches the planned posi…
Sponsor: DePuy Orthopaedics • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC